Gak Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-04-2024
- Paid Up Capital ₹ 0.10 M
as on 23-04-2024
- Company Age 13 Year, 28 Days
- Last Filing with ROC 31 Mar 2019
- Revenue %
(FY 2017)
- Profit 79.17%
(FY 2017)
- Ebitda -1267.83%
(FY 2017)
- Net Worth -0.99%
(FY 2017)
- Total Assets 7.71%
(FY 2017)
About Gak Pharma
- CIN/LLPIN
U51900MH2011PTC224250
- Company No.
224250
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Nov 2011
- Date of AGM
28 May 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gak Pharma?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Samved Khanolkar | Director | 24-Dec-2014 | Current |
Franklin Fernandes | Director | 22-Nov-2011 | Current |
Girish Amonker | Director | 22-Nov-2011 | Current |
Financial Performance and Corporate Structure Insights of Gak Pharma.
Gak Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 79.17% increase in profit. The company's net worth dipped by a decrease of 0.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Gak Pharma?
In 2017, Gak Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Seven Greens Solar Systems Private LimitedActive 13 years 5 months
Girish Amonker is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gak Pharma?
Unlock and access historical data on people associated with Gak Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gak Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gak Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.